课题基金 / 基金详情

Multimodal MRI Studies of Brain Structure and Function in PDD and AD

Multimodal MRI Studies of Brain Structure and Function in PDD and AD
PDD 和 AD 脑结构和功能的多模态 MRI 研究
批准号:
8197451
负责人:
JAMES B BREWER
金额:
$19.07万
依托单位国家:
美国
项目类别:
财政年份:
2009
资助国家:
美国
项目状态:
已结题
起止时间:
2009-12-01 至 2014-11-30

项目摘要

项目成果

JAMES B BREWER的其他基金

相似基金

相关文献

中文摘要
翻译
描述(由申请人提供): 摘要:在这个K02独立科学家职业发展奖,候选人寻求建立在他的功能和结构神经成像的背景,并使用多模态神经成像来了解认知障碍的演变,如帕金森氏病痴呆症(PDD)和阿尔茨海默氏病(AD)。K02将为候选人提供受保护的研究和职业发展活动时间,这将增强其成像专业知识的临床适用性,并确保在负责任的人类受试者研究中表现出色。拟议的项目使用多模态磁共振成像(MRI)来检查PDD和AD患者相对于老年对照组的大脑结构和功能差异。这项研究的总体目标是更好地了解大脑区域对突触核蛋白和淀粉样蛋白病理学的选择性脆弱性,并了解痴呆症的认知缺陷如何与大脑结构和电路的潜在损伤相关。具体而言,具有临床和神经心理学特征的对照组和PDD和AD受试者将接受约30分钟的基线和随访静息MRI方案,以进行以下测量:1)皮质和皮质下结构的区域体积,2)使用基于概率图谱的扩散张量纤维束成像识别的纤维束中的白色物质完整性,3)默认网络的解剖学定义区域内的功能连接,以及4)使用序列图像数据集的非线性配准的皮质和皮质下结构的体积的间隔变化。高通量的处理流程已经到位,可以有效地捕获从每个程序中获得的结构测量结果,候选人的实验室增加了功能连接分析方面的专业知识。因此,拟议的研究将允许对神经退行性疾病的结构和功能后果的新见解。 公共卫生相关性: 叙述:这项研究的目的是利用非侵入性脑成像来提高对痴呆症对脑结构影响的理解。这些信息可以帮助研究人员评估针对痴呆症不同病因的新疗法的疾病改善效果。脑结构的快速定量评估在临床上可能是实用的,以帮助临床医生更早,更准确地诊断神经退行性疾病。
英文摘要
DESCRIPTION (provided by applicant): ABSTRACT: In this K02 Independent Scientist Career Development Award, the candidate seeks to build upon his background in functional and structural neuroimaging and use multimodal neuroimaging to understand the evolution of cognitive disorders, such as Parkinson's disease dementia (PDD) and Alzheimer's disease (AD). The K02 will provide the candidate protected time for research and career development activities that will enhance the clinical applicability of his imaging expertise and assure excellence in the responsible conduct of human subject research. The proposed projects use multimodal magnetic resonance imaging (MRI) to examine structural and functional differences in the brains of patients with PDD and AD relative to elderly controls. The overall goal of the research is to better understand the selective vulnerability of brain regions to synuclein and amyloid pathology and to understand how cognitive deficits in dementia relate to underlying damage in brain structure and circuitry. Specifically, clinically and neuropsychologically characterized controls and subjects with PDD and AD will undergo a baseline and followup resting MRI protocol of around 30 minutes that will allow the following measurements: 1) regional volume of cortical and subcortical structures, 2) white matter integrity in tracts identified using probabilistic atlas-based diffusion tensor tractography, 3) functional connectivity within anatomically-defined regions of the default network, and 4) interval change in volume of cortical and subcortical structures using nonlinear registration of serial image datasets. High throughput processing streams are in place for efficiently capturing the structural measures obtained from each procedure, and the candidate's laboratory has added expertise in functional connectivity analysis. Thus, the proposed research will allow new insight into the structural and functional consequences of neurodegenerative disease. PUBLIC HEALTH RELEVANCE: NARRATIVE: The proposed research aims to improve understanding of the effects of dementia on brain structure using noninvasive brain imaging. Such information may help researchers evaluate disease-modifying effects of new therapies designed to target different causes of dementia. Rapid quantitative assessment of brain structure might be practical in the clinical setting to assist clinicians in making earlier and more accurate diagnoses of neurodegenerative diseases.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Multidisciplinary training in basic and translational Alzheimer's disease research
Multidisciplinary training in basic and translational Alzheimer's disease research
UCSD Alzheimer's Disease Research Centers P30
UCSD Alzheimer's Disease Research Centers P30
国内基金
海外基金
新型F-18标记香豆素衍生物PET探针的研制及靶向Alzheimer's Disease 斑块显像研究
  • 批准号:
    81000622
  • 项目类别:
    青年科学基金项目
  • 资助金额:
    20.0万元
  • 批准年份:
    2010
  • 负责人:
    梁胜
  • 依托单位:
阿尔茨海默病(Alzheimer's disease,AD)动物模型构建的分子机理研究
  • 批准号:
    31060293
  • 项目类别:
    地区科学基金项目
  • 资助金额:
    26.0万元
  • 批准年份:
    2010
  • 负责人:
    郭亚芬
  • 依托单位:
跨膜转运蛋白21(TMP21)对引起阿尔茨海默病(Alzheimer'S Disease)的γ分泌酶的作用研究